Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Chang

Showing results (21-30 of 169) with videos related to

Pageof 17
Sort By:
Cancer Immunology, Immunotherapy : CII|November 1, 1995
Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cellsA Aruga, S Shu, A E Chang
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2H Yoshizawa, A E Chang, S Shu
Cellular Immunology|August 1, 1990
Effector phenotype and immunologic specificity of T-cell-mediated adoptive therapy for a murine tumor that lacks intrinsic immunogenicityK Sakai, A E Chang, S Shu
Cancer Research|August 1, 1997
Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvantA Aruga, E Aruga, A E Chang
The Journal of Surgical Research|August 1, 1992
Divergent effects of TNF alpha in the adoptive immunotherapy of a murine sarcomaP D Wagner, S Shu, A E Chang
The American Surgeon|July 1, 1985
Interruption of the inferior vena cava for the prevention of recurrent pulmonary embolismM Mansour, A E Chang, W F Sindelar
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificityT Chou, A E Chang, S Y Shu
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagentsS Shu, J J Sussman, A E Chang
Cancer Research|March 1, 1992
Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cellsH Yoshizawa, A E Chang, S Y Shu
Cancer Research|July 15, 1990
Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcomaK Sakai, A E Chang, S Y Shu
Pageof 17

Showing results (21-30 of 169) with videos related to

Sort By:
Pageof 17
Cancer Immunology, Immunotherapy : CII|November 1, 1995
Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cellsA Aruga, S Shu, A E Chang
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1991
Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2H Yoshizawa, A E Chang, S Shu
Cellular Immunology|August 1, 1990
Effector phenotype and immunologic specificity of T-cell-mediated adoptive therapy for a murine tumor that lacks intrinsic immunogenicityK Sakai, A E Chang, S Shu
Cancer Research|August 1, 1997
Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvantA Aruga, E Aruga, A E Chang
The Journal of Surgical Research|August 1, 1992
Divergent effects of TNF alpha in the adoptive immunotherapy of a murine sarcomaP D Wagner, S Shu, A E Chang
The American Surgeon|July 1, 1985
Interruption of the inferior vena cava for the prevention of recurrent pulmonary embolismM Mansour, A E Chang, W F Sindelar
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1988
Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificityT Chou, A E Chang, S Y Shu
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagentsS Shu, J J Sussman, A E Chang
Cancer Research|March 1, 1992
Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cellsH Yoshizawa, A E Chang, S Y Shu
Cancer Research|July 15, 1990
Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcomaK Sakai, A E Chang, S Y Shu
Pageof 17